Dividends and the share repurchase programs of the Novo Group companies (Novo Nordisk and Novonesis) totaled 23 billion Danish kroner, and Returns from the Investment Portfolio generated an income ...

These questions have driven Professor Julia Vorholt's groundbreaking research work, which has now earned her the 2025 Novonesis Biotechnology Prize, awarded by the Novo Nordisk Foundation.